РусскийEnglish (UK)
     
 

Публикации с 2016 года

Кол-во строк: 
# Заголовок
21 The role of monocytosis and neutrophilia in atherosclerosis.

Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN.
J Cell Mol Med. 2018 Jan 24. doi: 10.1111/jcmm.13462. [Epub ahead of print]

22 New biomarkers for diagnosis and prognosis of localized prostate cancer.

Chistiakov DA, Myasoedova VA, Grechko AV, Melnichenko AA, Orekhov AN.
Semin Cancer Biol. 2018 Jan 19. pii: S1044-579X(17)30288-2. doi: 10.1016/j.semcancer.2018.01.012. [Epub ahead of print]

23 Mutations of nuclear and mitochondrial genomes as potential targets for the treatment of metabolic syndrome.

Galitsyn EV, Zhelankin AV, Sobenin IA, Orekhov AN.

Curr Pharm Des. 2018 Jan 15. doi: 10.2174/1381612824666180115120725. [Epub ahead of print]

24 Modified lipoproteins as biomarkers of atherosclerosis.

Orekhov AN, Sobenin IA.

Front Biosci (Landmark Ed). 2018 Mar 1;23:1422-1444.

25 Influence of autophagy on the genesis and development of atherosclerosis and its risk factors.

Sazonova MA, Sinev VV, Karagodin VP, Ryzhkova AI, Galitsyna EV, Barinova VA, Zelinyĭ RI, Nikitina NA, Orekhov AN.

Angiol Sosud Khir. 2017;23(4):20-28.

26 Calcifying Matrix Vesicles and Atherosclerosis.

Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN.

Biomed Res Int. 2017;2017:7463590. doi: 10.1155/2017/7463590. Epub 2017 Nov 7.

27 The role of mitochondrial dysfunction in cardiovascular disease: a brief review.

Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN.

Ann Med. 2017 Dec 18:1-7. doi: 10.1080/07853890.2017.1417631. [Epub ahead of print]

28 [Study of mitochondrial dysfunction using cytoplasmic hybrid].

Sinyov VV, Sazonova MA, Karagodin VP, Ryzhkova AI, Galitsyna EV, Melnichenko AA, Demakova NA, Shkurat TP, Sobenin IA, Orekhov AN.

Patol Fiziol Eksp Ter. 2017 Apr-Jun;61(2):92-7.

29 Engineered nanoparticles: Their properties and putative applications for therapeutic approaches utilizing stem cells for the repair of atherosclerotic disease.

Chistiakov DA, Melnichenko AA, Orekhov AN, Bobryshev YV.

Curr Drug Targets. 2017 Oct 27. doi: 10.2174/1389450118666171027111528. [Epub ahead of print]

30 The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2

Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV.

Immunobiology. 2017 Oct 5. pii: S0171-2985(17)30140-7. doi: 10.1016/j.imbio.2017.10.005. [Epub ahead of print]